SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 37 filers reported holding SQZ BIOTECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,292 | -48.5% | 15,896 | +6.8% | 0.00% | – |
| Q1 2023 | $8,335 | -38.1% | 14,884 | -18.2% | 0.00% | – |
| Q4 2022 | $13,468 | -76.8% | 18,200 | -29.4% | 0.00% | – |
| Q3 2022 | $58,000 | -61.8% | 25,795 | -46.3% | 0.00% | – |
| Q2 2022 | $152,000 | +7.8% | 48,026 | +63.4% | 0.00% | – |
| Q1 2022 | $141,000 | -63.7% | 29,392 | -32.3% | 0.00% | – |
| Q4 2021 | $388,000 | -23.2% | 43,439 | +24.1% | 0.00% | – |
| Q3 2021 | $505,000 | +2.9% | 34,990 | +3.0% | 0.00% | – |
| Q2 2021 | $491,000 | +41.1% | 33,976 | +33.6% | 0.00% | – |
| Q1 2021 | $348,000 | -40.6% | 25,431 | +25.7% | 0.00% | – |
| Q4 2020 | $586,000 | – | 20,234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,606,309 | $900 | 0.05% |
| Sandy Cove Advisors, LLC | 51,707 | $28,956 | 0.02% |
| MAVERICK CAPITAL LTD | 1,051,771 | $588,992 | 0.02% |
| Temasek Holdings (Private) Ltd | 2,758,169 | $1,544,575 | 0.01% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,517,173 | $1,409,617 | 0.01% |
| RBF Capital, LLC | 74,674 | $41,817 | 0.00% |
| Laurion Capital Management LP | 431,400 | $241,584 | 0.00% |
| Virtu Financial LLC | 17,075 | $10 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 65,800 | $36,848 | 0.00% |
| Bangor Savings Bank | 11,357 | $6,360 | 0.00% |